Abstract
Institutions in France are not yet well prepared to respond to allegations of scientific misconduct. Following a serious allegation in late 1997. INSERM,* the primary organization for medical and health-related research in France, began to reflect on this subject, aided by scientists and jurists. The conclusions have resulted in establishing a procedure to be followed in cases of alleged misconduct, and also in reinforcing the application of good laboratory practices within each laboratory. Guidelines for authorship practices and scientific assessment must also be considered. Even though each institution must remain responsible for responding to allegations of scientific misconduct within its doors, INSERM would like to see national, European, and international co-ordination about the methods of such response.
Similar content being viewed by others
References
Deutsche Forschungsgemenschaft (1998) Safeguarding good scientific practice, Wiley-VCH verlag GmbH, Weinheim.
Principles in the Assessment and Conduct of Medical Research and Publicising Results (1995) Medical Research Council, London.
MRC Policy and Procedure for inquiring into allegations of Scientific Misconduct (December, 1997) Medical Research Council, London.
ORI Handbook for Institutional Research Integrity Officers, mimeograph (February 1997) Department of Health and Human Services. Office of Research Integrity, Public Health Service, Washington D.C.
Author information
Authors and Affiliations
Additional information
Institut National de la Santé et de la Recherche Médicale (eng. French National Medical Research Institute) is known as INSERM.
Rights and permissions
About this article
Cite this article
Breittmayer, JP., Bungener, M., De The, H. et al. Responding to allegations of scientific misconduct. SCI ENG ETHICS 6, 41–48 (2000). https://doi.org/10.1007/s11948-000-0021-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11948-000-0021-3